cerebral artery Search Results


double giant fusiform aneurysms of the posterior cerebral artery  (Statham Instruments Inc)
90
Statham Instruments Inc double giant fusiform aneurysms of the posterior cerebral artery
Double Giant Fusiform Aneurysms Of The Posterior Cerebral Artery, supplied by Statham Instruments Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/double giant fusiform aneurysms of the posterior cerebral artery/product/Statham Instruments Inc
Average 90 stars, based on 1 article reviews
double giant fusiform aneurysms of the posterior cerebral artery - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
middle cerebral artery occlusion  (Johns Hopkins HealthCare)
90
Johns Hopkins HealthCare middle cerebral artery occlusion
Middle Cerebral Artery Occlusion, supplied by Johns Hopkins HealthCare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/middle cerebral artery occlusion/product/Johns Hopkins HealthCare
Average 90 stars, based on 1 article reviews
middle cerebral artery occlusion - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
endothelin-1 middle cerebral artery in vivo stroke model  (Harlan Sprague Dawley)
90
Harlan Sprague Dawley endothelin-1 middle cerebral artery in vivo stroke model
Endothelin 1 Middle Cerebral Artery In Vivo Stroke Model, supplied by Harlan Sprague Dawley, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/endothelin-1 middle cerebral artery in vivo stroke model/product/Harlan Sprague Dawley
Average 90 stars, based on 1 article reviews
endothelin-1 middle cerebral artery in vivo stroke model - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
internal carotid artery  (Gallus BioPharmaceuticals)
90
Gallus BioPharmaceuticals internal carotid artery
Internal Carotid Artery, supplied by Gallus BioPharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/internal carotid artery/product/Gallus BioPharmaceuticals
Average 90 stars, based on 1 article reviews
internal carotid artery - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
sheep middle cerebral artery rings  (Klaas LLC)
90
Klaas LLC sheep middle cerebral artery rings
Sheep Middle Cerebral Artery Rings, supplied by Klaas LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sheep middle cerebral artery rings/product/Klaas LLC
Average 90 stars, based on 1 article reviews
sheep middle cerebral artery rings - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
transient middle cerebral artery occlusion (tmcao) model  (Dawley Inc)
90
Dawley Inc transient middle cerebral artery occlusion (tmcao) model
Protective roles of H 2 S donors in neurological disease models
Transient Middle Cerebral Artery Occlusion (Tmcao) Model, supplied by Dawley Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/transient middle cerebral artery occlusion (tmcao) model/product/Dawley Inc
Average 90 stars, based on 1 article reviews
transient middle cerebral artery occlusion (tmcao) model - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
right middle cerebral artery ligation  (Dawley Inc)
90
Dawley Inc right middle cerebral artery ligation
Protective roles of H 2 S donors in neurological disease models
Right Middle Cerebral Artery Ligation, supplied by Dawley Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/right middle cerebral artery ligation/product/Dawley Inc
Average 90 stars, based on 1 article reviews
right middle cerebral artery ligation - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
6–0 fine middle cerebral artery occlusion (mcao) suture  (Doccol Corporation)
90
Doccol Corporation 6–0 fine middle cerebral artery occlusion (mcao) suture
Loss of CLEC14A <t>exacerbated</t> <t>cerebral</t> injury with VEGFR2 activation in <t>MCAO</t> stroke model. a , c Images of whole brains and comparison of Evans blue dye (EB) leakage in brains (P8 and adult) after EB injection (intraperitoneal route) in WT and CLEC14A KO mice ( n = 6, each group). b , d The quantitative analysis of Evans blue (EB) dye extravasation using spectrophotometer, 24 h after intraperitoneal injection of EB dye. e TTC staining of brain slices in the sham, WT, and CLEC14A KO groups 24-h post ischemia-reperfusion. Severe infarction was present in the CLEC14A KO group. Scale bar = 1 mm. f Percentage of infarct volume in the WT and CLEC14A KO groups 24 h after ischemia-reperfusion. g Neurological scores of WT and CLEC14A KO mice were evaluated. h VEGFR2, pVEGFR2 protein expression in ipsilateral brain lysate after ischemia-reperfusion injury. i , j Quantification data of relative pVEGFR2 and VEGFR2 protein expression. n = 6 per group; * P < 0.05, ** P < 0.01, *** P < 0.001. The results are mean values and the error bars represent the mean ± SD
6–0 Fine Middle Cerebral Artery Occlusion (Mcao) Suture, supplied by Doccol Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/6–0 fine middle cerebral artery occlusion (mcao) suture/product/Doccol Corporation
Average 90 stars, based on 1 article reviews
6–0 fine middle cerebral artery occlusion (mcao) suture - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
cerebrence  (Arterial Vascular Engineering Inc)
90
Arterial Vascular Engineering Inc cerebrence
Loss of CLEC14A <t>exacerbated</t> <t>cerebral</t> injury with VEGFR2 activation in <t>MCAO</t> stroke model. a , c Images of whole brains and comparison of Evans blue dye (EB) leakage in brains (P8 and adult) after EB injection (intraperitoneal route) in WT and CLEC14A KO mice ( n = 6, each group). b , d The quantitative analysis of Evans blue (EB) dye extravasation using spectrophotometer, 24 h after intraperitoneal injection of EB dye. e TTC staining of brain slices in the sham, WT, and CLEC14A KO groups 24-h post ischemia-reperfusion. Severe infarction was present in the CLEC14A KO group. Scale bar = 1 mm. f Percentage of infarct volume in the WT and CLEC14A KO groups 24 h after ischemia-reperfusion. g Neurological scores of WT and CLEC14A KO mice were evaluated. h VEGFR2, pVEGFR2 protein expression in ipsilateral brain lysate after ischemia-reperfusion injury. i , j Quantification data of relative pVEGFR2 and VEGFR2 protein expression. n = 6 per group; * P < 0.05, ** P < 0.01, *** P < 0.001. The results are mean values and the error bars represent the mean ± SD
Cerebrence, supplied by Arterial Vascular Engineering Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cerebrence/product/Arterial Vascular Engineering Inc
Average 90 stars, based on 1 article reviews
cerebrence - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
standard doccol 0.21 0.02mm width filament  (Doccol Corporation)
90
Doccol Corporation standard doccol 0.21 0.02mm width filament
Loss of CLEC14A <t>exacerbated</t> <t>cerebral</t> injury with VEGFR2 activation in <t>MCAO</t> stroke model. a , c Images of whole brains and comparison of Evans blue dye (EB) leakage in brains (P8 and adult) after EB injection (intraperitoneal route) in WT and CLEC14A KO mice ( n = 6, each group). b , d The quantitative analysis of Evans blue (EB) dye extravasation using spectrophotometer, 24 h after intraperitoneal injection of EB dye. e TTC staining of brain slices in the sham, WT, and CLEC14A KO groups 24-h post ischemia-reperfusion. Severe infarction was present in the CLEC14A KO group. Scale bar = 1 mm. f Percentage of infarct volume in the WT and CLEC14A KO groups 24 h after ischemia-reperfusion. g Neurological scores of WT and CLEC14A KO mice were evaluated. h VEGFR2, pVEGFR2 protein expression in ipsilateral brain lysate after ischemia-reperfusion injury. i , j Quantification data of relative pVEGFR2 and VEGFR2 protein expression. n = 6 per group; * P < 0.05, ** P < 0.01, *** P < 0.001. The results are mean values and the error bars represent the mean ± SD
Standard Doccol 0.21 0.02mm Width Filament, supplied by Doccol Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/standard doccol 0.21 0.02mm width filament/product/Doccol Corporation
Average 90 stars, based on 1 article reviews
standard doccol 0.21 0.02mm width filament - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
model of sprague dawley rat middle cerebral artery occlusion  (Dawley Inc)
90
Dawley Inc model of sprague dawley rat middle cerebral artery occlusion
Loss of CLEC14A <t>exacerbated</t> <t>cerebral</t> injury with VEGFR2 activation in <t>MCAO</t> stroke model. a , c Images of whole brains and comparison of Evans blue dye (EB) leakage in brains (P8 and adult) after EB injection (intraperitoneal route) in WT and CLEC14A KO mice ( n = 6, each group). b , d The quantitative analysis of Evans blue (EB) dye extravasation using spectrophotometer, 24 h after intraperitoneal injection of EB dye. e TTC staining of brain slices in the sham, WT, and CLEC14A KO groups 24-h post ischemia-reperfusion. Severe infarction was present in the CLEC14A KO group. Scale bar = 1 mm. f Percentage of infarct volume in the WT and CLEC14A KO groups 24 h after ischemia-reperfusion. g Neurological scores of WT and CLEC14A KO mice were evaluated. h VEGFR2, pVEGFR2 protein expression in ipsilateral brain lysate after ischemia-reperfusion injury. i , j Quantification data of relative pVEGFR2 and VEGFR2 protein expression. n = 6 per group; * P < 0.05, ** P < 0.01, *** P < 0.001. The results are mean values and the error bars represent the mean ± SD
Model Of Sprague Dawley Rat Middle Cerebral Artery Occlusion, supplied by Dawley Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/model of sprague dawley rat middle cerebral artery occlusion/product/Dawley Inc
Average 90 stars, based on 1 article reviews
model of sprague dawley rat middle cerebral artery occlusion - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
basilar- and middle cerebral arteries  (Dawley Inc)
90
Dawley Inc basilar- and middle cerebral arteries
Loss of CLEC14A <t>exacerbated</t> <t>cerebral</t> injury with VEGFR2 activation in <t>MCAO</t> stroke model. a , c Images of whole brains and comparison of Evans blue dye (EB) leakage in brains (P8 and adult) after EB injection (intraperitoneal route) in WT and CLEC14A KO mice ( n = 6, each group). b , d The quantitative analysis of Evans blue (EB) dye extravasation using spectrophotometer, 24 h after intraperitoneal injection of EB dye. e TTC staining of brain slices in the sham, WT, and CLEC14A KO groups 24-h post ischemia-reperfusion. Severe infarction was present in the CLEC14A KO group. Scale bar = 1 mm. f Percentage of infarct volume in the WT and CLEC14A KO groups 24 h after ischemia-reperfusion. g Neurological scores of WT and CLEC14A KO mice were evaluated. h VEGFR2, pVEGFR2 protein expression in ipsilateral brain lysate after ischemia-reperfusion injury. i , j Quantification data of relative pVEGFR2 and VEGFR2 protein expression. n = 6 per group; * P < 0.05, ** P < 0.01, *** P < 0.001. The results are mean values and the error bars represent the mean ± SD
Basilar And Middle Cerebral Arteries, supplied by Dawley Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/basilar- and middle cerebral arteries/product/Dawley Inc
Average 90 stars, based on 1 article reviews
basilar- and middle cerebral arteries - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Protective roles of H 2 S donors in neurological disease models

Journal: Neurochemical Research

Article Title: Hydrogen Sulphide-Based Therapeutics for Neurological Conditions: Perspectives and Challenges

doi: 10.1007/s11064-023-03887-y

Figure Lengend Snippet: Protective roles of H 2 S donors in neurological disease models

Article Snippet: Stroke , Sprague–Dawley rats. Transient middle cerebral artery occlusion (tMCAO) model. 1.5 h ischemia and 24 h reperfusion , GYY4137 (1 mM in 5μL) was injected in the lateral cerebral ventricle just before reperfusion , [ ] .

Techniques: Injection, Transformation Assay, Transgenic Assay, Mutagenesis, Isolation, Cell Culture, Saline

Loss of CLEC14A exacerbated cerebral injury with VEGFR2 activation in MCAO stroke model. a , c Images of whole brains and comparison of Evans blue dye (EB) leakage in brains (P8 and adult) after EB injection (intraperitoneal route) in WT and CLEC14A KO mice ( n = 6, each group). b , d The quantitative analysis of Evans blue (EB) dye extravasation using spectrophotometer, 24 h after intraperitoneal injection of EB dye. e TTC staining of brain slices in the sham, WT, and CLEC14A KO groups 24-h post ischemia-reperfusion. Severe infarction was present in the CLEC14A KO group. Scale bar = 1 mm. f Percentage of infarct volume in the WT and CLEC14A KO groups 24 h after ischemia-reperfusion. g Neurological scores of WT and CLEC14A KO mice were evaluated. h VEGFR2, pVEGFR2 protein expression in ipsilateral brain lysate after ischemia-reperfusion injury. i , j Quantification data of relative pVEGFR2 and VEGFR2 protein expression. n = 6 per group; * P < 0.05, ** P < 0.01, *** P < 0.001. The results are mean values and the error bars represent the mean ± SD

Journal: Journal of Neuroinflammation

Article Title: CLEC14A deficiency exacerbates neuronal loss by increasing blood-brain barrier permeability and inflammation

doi: 10.1186/s12974-020-1727-6

Figure Lengend Snippet: Loss of CLEC14A exacerbated cerebral injury with VEGFR2 activation in MCAO stroke model. a , c Images of whole brains and comparison of Evans blue dye (EB) leakage in brains (P8 and adult) after EB injection (intraperitoneal route) in WT and CLEC14A KO mice ( n = 6, each group). b , d The quantitative analysis of Evans blue (EB) dye extravasation using spectrophotometer, 24 h after intraperitoneal injection of EB dye. e TTC staining of brain slices in the sham, WT, and CLEC14A KO groups 24-h post ischemia-reperfusion. Severe infarction was present in the CLEC14A KO group. Scale bar = 1 mm. f Percentage of infarct volume in the WT and CLEC14A KO groups 24 h after ischemia-reperfusion. g Neurological scores of WT and CLEC14A KO mice were evaluated. h VEGFR2, pVEGFR2 protein expression in ipsilateral brain lysate after ischemia-reperfusion injury. i , j Quantification data of relative pVEGFR2 and VEGFR2 protein expression. n = 6 per group; * P < 0.05, ** P < 0.01, *** P < 0.001. The results are mean values and the error bars represent the mean ± SD

Article Snippet: A 6–0 fine middle cerebral artery occlusion (MCAO) suture (Doccol Corporation, Sharon, MA) was inserted into the lumen of the right external carotid artery stump.

Techniques: Activation Assay, Comparison, Injection, Spectrophotometry, Staining, Expressing